You need to enable JavaScript to run this app.
☰
×
About
Methodology
The Team
News
Conference
Contact Us
About
Methodology
The Team
News
Conference
Contact Us
Adult Panic Disorder
Adult Panic Disorder
Diagnosis
Medication
Recommendation
Adequate pharmacotherapy trial: minimum 6-8 weeks at maximum clinically indicated and tolerable dose.
Medication History
Currently or has previously taken medication to treat Panic Disorder
X
Severe
anxiety/panic
Adequate response
Adequate response
Inadequate response
Partial response
No
Inadequate
response
Consider TCA prior
to chronic benzodiazepines
Yes
Partial
response
Combination SSRI/SNRI
and TCA therapy requires
careful patient selection, education,
shared decision making, and monitoring
Combination
Panic Disorder
Consider adjunctive prn
Benzodiazepine:
Clonazepam or Lorazepam,
ideally <4 weeks
SOR A
Psychotherapy:
Cognitive behavioral therapy
SOR A
SSRI or SNRI
initiated at lowest doses
SOR A
Follow up and titrate dose
as appropriate q 1-2 weeks for active
medication management
Maintain effective pharmacotherapy for
minimum of 12 months;
if asymptomatic for 4-6 months,
consider slow taper
SOR A
Max dose NOT
achieved due to
side effects
Continue SSRI/SNRI;
augment with Mirtazapine
Follow up and titrate dose
as appropriate q 1-2 weeks for active
medication management
Continue SSRI/SNRI and
Mirtazapine
Max dose achieved
with inadequate
response
First time failing an
SSRI or SNRI?
Discontinue
current
medication
Trial Mirtazapine
SOR B
Discontinue Mirtazapine
Trial of alternate pharmacotherapy
TCA
SOR A
Imipramine most studied,
other TCAs reasonable
Benzodiazepine
Lorazepam
Clonazepam
Trial different
medication